Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.
2.

CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.

Bourguignon LY, Zhu D, Zhu H.

Front Biosci. 1998 Jul 1;3:d637-49. Review.

PMID:
9634539
3.

Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis.

Bourrguignon LY, Iida N, Welsh CF, Zhu D, Krongrad A, Pasquale D.

J Neurooncol. 1995 Dec;26(3):201-8. Review.

PMID:
8750186
4.

Mechanisms regulating the binding activity of CD44 to hyaluronic acid.

Liu D, Liu T, Li R, Sy MS.

Front Biosci. 1998 Jul 1;3:d631-6. Review.

PMID:
9634638
5.

Hyaluronan: RHAMM mediated cell locomotion and signaling in tumorigenesis.

Hall CL, Turley EA.

J Neurooncol. 1995 Dec;26(3):221-9. Review.

PMID:
8750188
7.

Are hyaluronan receptors involved in three-dimensional cell migration?

Nehls V, Hayen W.

Histol Histopathol. 2000 Apr;15(2):629-36. Review.

PMID:
10809384
8.

CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression.

Bourguignon LY.

J Mammary Gland Biol Neoplasia. 2001 Jul;6(3):287-97. Review.

PMID:
11547898
9.

CD44 in hematological neoplasias.

Hertweck MK, Erdfelder F, Kreuzer KA.

Ann Hematol. 2011 May;90(5):493-508. doi: 10.1007/s00277-011-1161-z. Epub 2011 Jan 22. Review.

PMID:
21258793
10.

Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.

Bourguignon LY, Shiina M, Li JJ.

Adv Cancer Res. 2014;123:255-75. doi: 10.1016/B978-0-12-800092-2.00010-1. Review.

PMID:
25081533
11.

Hyaluronan and cell locomotion.

Turley EA.

Cancer Metastasis Rev. 1992 Mar;11(1):21-30. Review.

PMID:
1380898
12.

The role of a cell-associated hyaluronan-binding protein in fibroblast behaviour.

Turley EA.

Ciba Found Symp. 1989;143:121-33; discussion 133-7, 281-5. Review.

PMID:
2478343
13.

Modulation of the hyaluronan receptor, CD44, by its transmembrane and cytoplasmic domains.

Sheikh H, Uff CR, Peck D, Isacke CM.

Biochem Soc Trans. 1995 Nov;23(4):831-5. Review. No abstract available.

PMID:
8654848
14.

Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.

Bourguignon LY.

Semin Cancer Biol. 2008 Aug;18(4):251-9. doi: 10.1016/j.semcancer.2008.03.007. Epub 2008 Mar 26. Review.

15.

CD44 structure and function.

Lesley J, Hyman R.

Front Biosci. 1998 Jul 1;3:d616-30. Review.

PMID:
9634544
16.

Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions.

Bourguignon LY.

Am J Pathol. 2014 Jul;184(7):1912-9. doi: 10.1016/j.ajpath.2014.03.010. Epub 2014 May 9. Review.

17.

Discrete domains within the hyaluronan receptor CD44 regulate membrane localization and cell migration.

Sheikh H, Legg J, Lewis C, Peck D, Isacke C.

Cell Adhes Commun. 1998;6(2-3):149-56. Review.

PMID:
9823466
18.

The role of the cytoplasmic domain in regulating CD44 function.

Isacke CM.

J Cell Sci. 1994 Sep;107 ( Pt 9):2353-9. Review. No abstract available.

19.

Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.

Ween MP, Oehler MK, Ricciardelli C.

Int J Mol Sci. 2011 Jan 31;12(2):1009-29. doi: 10.3390/ijms12021009. Review.

20.

[HS1 and EMS1].

He H.

Gan To Kagaku Ryoho. 1997 Sep;24(11):1448-53. Review. Japanese.

PMID:
9309140

Supplemental Content

Support Center